Skip to content
Altius – Lifestyle
Author:
ANNJI PHARMACEUTICAL CO. LTD
AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)
October 5, 2026